Covid-19: China’s CoronaVac vaccine offers 83.5% protection against symptomatic infection, interim analysis finds

Off BMJ, British Medical Journal, COVID-19, Science and Health, Science and Research, Uncategorized

Two doses of the new CoronaVac vaccine made in China have an efficacy of 83.5% against symptomatic covid-19, an interim analysis has shown.1The vaccine, developed by the Chinese company Sinovac Life…


Read Original Article: Covid-19: China’s CoronaVac vaccine offers 83.5% protection against symptomatic infection, interim analysis finds »

About The Author